文献速递慢性静脉疾病

上腔静脉综合征的当代管理

Contemporary management of superior vena cava syndrome.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-03-20

本文综述了上腔静脉综合征的血管内治疗文献。球囊扩张及支架置入已成为有症状患者的一线治疗,覆膜支架可能更安全,通畅率与非覆膜支架相当,且降低致命并发症风险。开放手术仍为备选。

要点

  • 球囊扩张联合支架置入是有症状上腔静脉综合征的一线治疗。
  • 覆膜支架可能降低破裂和心包填塞风险,通畅率与非覆膜支架相当。
  • 开放手术适用于不适合或反复介入失败的患者。

核心结论

  • 支架置入是恶性和良性病因所致有症状上腔静脉综合征的安全有效一线治疗,覆膜支架可能结局更好且并发症更少。

研究设计与样本

  • 本篇为基于已发表的上腔静脉综合征血管内治疗文献分析的综述。

主要发现

  • 球囊扩张和即刻支架置入已成为所有病因所致有症状上腔静脉综合征的一线治疗。
  • 多种支架(球囊扩张式、自膨式、编织型、激光切割镍钛合金、开环和闭环设计)均有使用,但比较性临床研究未显示任一类型优越。
  • 证据日益提示覆膜支架对上腔静脉阻塞更安全,通畅率与非覆膜支架相当,且降低破裂和心包填塞等致命并发症风险。
  • 对于恶性肿瘤患者,覆膜支架还可能减少肿瘤长入。
  • 开放手术使用螺旋大隐静脉移植物、股静脉和膨体聚四氟乙烯移植物,仍是不适合血管内介入或反复介入失败患者的可行选择。

临床怎么用

  • 有症状上腔静脉综合征可首选球囊扩张联合支架置入。
  • 选择支架时可考虑覆膜支架以降低致命并发症风险。
  • 不适合血管内介入或反复介入失败的患者可考虑开放手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Superior vena cava (SVC) syndrome is a rare but severe medical condition owing to obstruction of the venous return to the heart through the innominate veins and the SVC. Lung cancer is the most common malignant cause, while central vein thrombosis owing to intravenous lines and pacemaker wires as well as mediastinal fibrosis are the frequent benign etiologies. METHODS: This review is based on an analysis of published literature reporting the results of endovenous management of SVC syndrome. RESULTS: Endovenous treatment, with balloon angioplasty and immediate stenting, has become the first line of treatment of all causes of symptomatic SVC syndrome. Various stents have been used, including balloon and self-expanding stents, woven, braided, and laser-cut nitinol stents, as well as open- and closed-cell designs. However, no single type has demonstrated superiority in comparative clinical studies. Evidence increasingly suggests that covered stents are safer for SVC obstruction, offering patency rates comparable with noncovered stents while decreasing the risk of lethal complications such as rupture and pericardial tamponade. For patients with malignant disease, fabric-covered stents may also decrease tumor ingrowth. Open surgery remains a viable option using spiral saphenous vein graft, femoral vein, and expanded polytetrafluoroethylene graft for those who are not candidates for endovascular interventions or fail after repeat interventions. CONCLUSIONS: Stent placement is a safe and effective first-line treatment for symptomatic SVC syndrome of both malignant or benign etiologies, with likely better outcomes and fewer complications associated with using covered stents.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Sen I, Gloviczki P, Kalra M, et al. Contemporary management of superior vena cava syndrome. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 41866116. doi:10.1016/j.jvsv.2026.102491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。